Back to Search
JOANN ZELL, M.D.
M.D.
Rheumatology Physician
NPI: 1760415418IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
45196(CO)
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
45196(CO)
CMS Specialties
PrimaryRHEUMATOLOGY
Education
NORTHWESTERN UNIVERSITY FEINBERG MEDICAL SCHOOL
Class of 1999
Research & Publications (20)
Risk of cardiovascular events in a randomized placebo-controlled, double-blind trial of difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas.
PMID 19258540·Cancer Prev Res (Phila)·2009
2-rct
Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment.
PMID 18165642·J Clin Oncol·2008
8-other
Survival improvements for advanced stage nonbronchioloalveolar carcinoma-type nonsmall cell lung cancer cases with ipsilateral intrapulmonary nodules.
PMID 17960795·Cancer·2008
4-observational
Survival after colorectal cancer diagnosis is associated with colorectal cancer family history.
PMID 18990755·Cancer Epidemiol Biomarkers Prev·2008
8-other
Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California.
PMID 17372250·Cancer Epidemiol Biomarkers Prev·2007
8-other
Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology.
PMID 17060483·Ann Oncol·2007
8-other
Long-term survival differences for bronchiolo-alveolar carcinoma patients with ipsilateral intrapulmonary metastasis at diagnosis.
PMID 16766595·Ann Oncol·2006
8-other
Neoplastic fever: a neglected paraneoplastic syndrome.
PMID 15864658·Support Care Cancer·2005
6-review
Epidemiology of bronchioloalveolar carcinoma: improvement in survival after release of the 1999 WHO classification of lung tumors.
PMID 16293870·J Clin Oncol·2005
8-other
Precore mutant hepatitis B reactivation after treatment with CHOP-rituximab.
PMID 15613909·Anticancer Drugs·2005
5-case
Regulation of mdm2 mRNA expression in human breast tumor-derived GI-101A cells.
PMID 12231395·Life Sci·2002
7-preclinical
Prognostic factors for survival in extensive stage small cell lung cancer (ED-SCLC): the importance of smoking history, socioeconomic and marital statuses, and ethnicity.
PMID 19096304·J Thorac Oncol·2009
8-other
Asian ethnicity is a favorable prognostic factor for overall survival in non-small cell lung cancer (NSCLC) and is independent of smoking status.
PMID 19652625·J Thorac Oncol·2009
8-other
Tumor subsite location within the colon is prognostic for survival after colon cancer diagnosis.
PMID 19617745·Dis Colon Rectum·2009
4-observational
The effect of tumor size on non-size-based descriptors in staging of stage I non-small cell lung cancer.
PMID 19497911·Chest·2009
8-other
Need for a new treatment strategy: leptomeningeal carcinomatosis from gastric cancer.
PMID 19247177·Anticancer Drugs·2009
5-case
Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry.
PMID 19228416·Breast Cancer Res·2009
8-other
The applicability of the proposed IASLC staging revisions to small cell lung cancer (SCLC) with comparison to the current UICC 6th TNM Edition.
PMID 19156001·J Thorac Oncol·2009
4-observational
Survival of distinct Asian groups among colorectal cancer cases in California.
PMID 19109815·Cancer·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 12605 E 16TH AVE
AURORA, CO 80045 - Phone
- (720) 848-0000
Quick Facts
- NPI
- 1760415418
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 3
- Years in Practice
- 27
- Publications
- 20
Are you this provider?
Claim Your Profile